MALDI-TOF MS for rapid detection and differentiation between Tet(X)-producers and non-Tet(X)-producing tetracycline-resistant Gram-negative bacteria

Virulence. 2022 Dec;13(1):77-88. doi: 10.1080/21505594.2021.2018768.

Abstract

The extensive use of tetracycline antibiotics has led to the widespread presence of tetracycline-resistance genes in Gram-negative bacteria and this poses serious threats to human and animal health. In our previous study, we reported a method for rapid detection of Tet(X)-producers using MALDI-TOF MS. However, there have been multiple machineries involved in tetracycline resistance including efflux pump, and ribosomal protection protein. Our previous demonstrated the limitation in probing the non-Tet(X)-producing tetracycline-resistant strains. In this regard, we further developed a MALDI-TOF MS method to detect and differentiate Tet(X)-producers and non-Tet(X)-producing tetracycline-resistant strains. Test strains were incubated with tigecycline and oxytetracycline in separate tubes for 3 h and then analyzed spectral peaks of tigecycline, oxytetracycline, and their metabolite. Strains were distinguished using MS ratio for [metabolite/(metabolite+ tigecycline or oxytetracycline)]. Four control strains and 319 test strains were analyzed and the sensitivity was 98.90% and specificity was 98.34%. This was consistent with the results obtained from LC-MS/MS analysis. Interestingly, we also found that the reactive oxygen species (ROS) produced by tetracycline-susceptible strains were able to promote the degradation of oxytetracycline. Overall, the MALDITet(X)-plus test represents a rapid and reliable method to detect Tet(X)-producers, non-Tet(X)-producing tetracycline-resistant strains, and tetracycline-susceptible strains.

Keywords: MALDI-TOF MS; Rapid detection; Tet(X)-producers; non-Tet(X)-producers; phenotypic detection; tetracycline resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Chromatography, Liquid
  • Gram-Negative Bacteria / genetics
  • Microbial Sensitivity Tests
  • Oxytetracycline*
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods
  • Tandem Mass Spectrometry
  • Tetracycline* / pharmacology
  • Tigecycline / pharmacology

Substances

  • Anti-Bacterial Agents
  • Tigecycline
  • Tetracycline
  • Oxytetracycline

Grants and funding

This work was supported by the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (grant 2019BT02N054), the Guangdong Major Project of Basic and Applied Basic Research (grant 2020B0301030007), the Program for Innovative Research Team in the University of Ministry of Education of China (grant <#AWARD-ID;><#AWARD-ID;>IRT_17R39), and the 111 Project (grant 408 D20008).